All PlansCoverageMedium impact
Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS Syndrome
Blue Cross & Blue Shield of Mississippi·MS · Hematology, Oncology·Medical Policy
We identified it
Jun 20, 2026
Summary
This policy establishes coverage criteria for hematopoietic cell transplantation (HCT) for plasma cell disorders including multiple myeloma and POEMS syndrome. The policy defines medical necessity requirements for both autologous and allogeneic transplants, conditioning regimens, and treatment protocols.
Action Required
Billing team should review the policy criteria for hematopoietic cell transplantation claims for multiple myeloma and POEMS syndrome patients. Ensure documentation meets the established medical necessity requirements outlined in the policy. Verify patient eligibility and staging criteria before submitting transplant-related claims.